These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2756532)

  • 1. Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation.
    Flegel KM; Hanley J
    Stroke; 1989 Aug; 20(8):1000-4. PubMed ID: 2756532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation.
    Leung DY; Black IW; Cranney GB; Hopkins AP; Walsh WF
    J Am Coll Cardiol; 1994 Sep; 24(3):755-62. PubMed ID: 8077549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
    Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
    G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Haruki S; Minami Y; Hagiwara N
    Stroke; 2016 Apr; 47(4):936-42. PubMed ID: 26941260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries.
    Yuan Z; Bowlin S; Einstadter D; Cebul RD; Conners AR; Rimm AA
    Am J Public Health; 1998 Mar; 88(3):395-400. PubMed ID: 9518970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi.
    Stöllberger C; Chnupa P; Kronik G; Brainin M; Finsterer J; Schneider B; Slany J
    Ann Intern Med; 1998 Apr; 128(8):630-8. PubMed ID: 9537936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study.
    Moulton AW; Singer DE; Haas JS
    Am J Med; 1991 Aug; 91(2):156-61. PubMed ID: 1867242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
    Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
    J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.
    Singer DE; Hughes RA; Gress DR; Sheehan MA; Oertel LB; Maraventano SW; Blewett DR; Rosner B; Kistler JP
    Am Heart J; 1992 Dec; 124(6):1567-73. PubMed ID: 1462916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of embolic stroke in non-valvular atrial fibrillation (NVAF). An autopsy study.
    Yamanouchi H; Shimada H; Tomonaga M; Matsushita S
    Acta Neurol Scand; 1989 Aug; 80(2):123-9. PubMed ID: 2816274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE.
    Goto S; Merrill P; Wallentin L; Wojdyla DM; Hanna M; Avezum A; Easton JD; Harjola VP; Huber K; Lewis BS; Parkhomenko A; Zhu J; Granger CB; Lopes RD; Alexander JH
    Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):75-81. PubMed ID: 29385429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation. European Atrial Fibrillation Trial (EAFT) Study Group.
    van Latum JC; Koudstaal PJ; Venables GS; van Gijn J; Kappelle LJ; Algra A
    Stroke; 1995 May; 26(5):801-6. PubMed ID: 7740570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1273-7. PubMed ID: 9565007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
    Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
    N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke.
    Jones EF; Calafiore P; McNeil JJ; Tonkin AM; Donnan GA
    Am J Cardiol; 1996 Aug; 78(4):425-9. PubMed ID: 8752187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac rhythm and systemic embolism in long-term follow up of patients with non-valvular paroxysmal atrial fibrillation].
    Bugueño C; Corbalán R; Braun S; Tapia J; Kramer A; Huete I; Chávez A
    Rev Med Chil; 1998 Jun; 126(6):646-54. PubMed ID: 9778872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
    Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Ibáñez CL; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
    Am J Cardiol; 2011 May; 107(10):1489-93. PubMed ID: 21420049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
    Sandhu RK; Hohnloser SH; Pfeffer MA; Yuan F; Hart RG; Yusuf S; Connolly SJ; McAlister FA; Healey JS
    Stroke; 2015 Mar; 46(3):667-72. PubMed ID: 25628308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.
    European Atrial Fibrillation Trial Study Group
    N Engl J Med; 1995 Jul; 333(1):5-10. PubMed ID: 7776995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.